STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

Intrinsic Value

The intrinsic value of one STAA stock under the Base Case scenario is 22.19 USD. Compared to the current market price of 26.68 USD, STAAR Surgical Co is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
STAAR Surgical Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STAA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STAA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about STAAR Surgical Co

Provide an overview of the primary business activities
of STAAR Surgical Co.

What unique competitive advantages
does STAAR Surgical Co hold over its rivals?

What risks and challenges
does STAAR Surgical Co face in the near future?

Has there been any significant insider trading activity
in STAAR Surgical Co recently?

Summarize the latest earnings call
of STAAR Surgical Co.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for STAAR Surgical Co.

Provide P/S
for STAAR Surgical Co.

Provide P/E
for STAAR Surgical Co.

Provide P/OCF
for STAAR Surgical Co.

Provide P/FCFE
for STAAR Surgical Co.

Provide P/B
for STAAR Surgical Co.

Provide EV/S
for STAAR Surgical Co.

Provide EV/GP
for STAAR Surgical Co.

Provide EV/EBITDA
for STAAR Surgical Co.

Provide EV/EBIT
for STAAR Surgical Co.

Provide EV/OCF
for STAAR Surgical Co.

Provide EV/FCFF
for STAAR Surgical Co.

Provide EV/IC
for STAAR Surgical Co.

Show me price targets
for STAAR Surgical Co made by professional analysts.

What are the Revenue projections
for STAAR Surgical Co?

How accurate were the past Revenue estimates
for STAAR Surgical Co?

What are the Net Income projections
for STAAR Surgical Co?

How accurate were the past Net Income estimates
for STAAR Surgical Co?

What are the EPS projections
for STAAR Surgical Co?

How accurate were the past EPS estimates
for STAAR Surgical Co?

What are the EBIT projections
for STAAR Surgical Co?

How accurate were the past EBIT estimates
for STAAR Surgical Co?

Compare the revenue forecasts
for STAAR Surgical Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of STAAR Surgical Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of STAAR Surgical Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of STAAR Surgical Co compared to its peers.

Compare the P/E ratios
of STAAR Surgical Co against its peers.

Discuss the investment returns and shareholder value creation
comparing STAAR Surgical Co with its peers.

Analyze the financial leverage
of STAAR Surgical Co compared to its main competitors.

Show all profitability ratios
for STAAR Surgical Co.

Provide ROE
for STAAR Surgical Co.

Provide ROA
for STAAR Surgical Co.

Provide ROIC
for STAAR Surgical Co.

Provide ROCE
for STAAR Surgical Co.

Provide Gross Margin
for STAAR Surgical Co.

Provide Operating Margin
for STAAR Surgical Co.

Provide Net Margin
for STAAR Surgical Co.

Provide FCF Margin
for STAAR Surgical Co.

Show all solvency ratios
for STAAR Surgical Co.

Provide D/E Ratio
for STAAR Surgical Co.

Provide D/A Ratio
for STAAR Surgical Co.

Provide Interest Coverage Ratio
for STAAR Surgical Co.

Provide Altman Z-Score Ratio
for STAAR Surgical Co.

Provide Quick Ratio
for STAAR Surgical Co.

Provide Current Ratio
for STAAR Surgical Co.

Provide Cash Ratio
for STAAR Surgical Co.

What is the historical Revenue growth
over the last 5 years for STAAR Surgical Co?

What is the historical Net Income growth
over the last 5 years for STAAR Surgical Co?

What is the current Free Cash Flow
of STAAR Surgical Co?

Discuss the annual earnings per share (EPS)
trend over the past five years for STAAR Surgical Co.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
STAAR Surgical Co

Current Assets 397.1m
Cash & Short-Term Investments 236m
Receivables 108m
Other Current Assets 53.2m
Non-Current Assets 140.5m
PP&E 119.6m
Intangibles 1.8m
Other Non-Current Assets 19.1m
Current Liabilities 66.3m
Accounts Payable 14.7m
Accrued Liabilities 25.7m
Other Current Liabilities 26m
Non-Current Liabilities 43.1m
Other Non-Current Liabilities 43.1m
Efficiency

Earnings Waterfall
STAAR Surgical Co

Revenue
341.2m USD
Cost of Revenue
-72.6m USD
Gross Profit
268.7m USD
Operating Expenses
-243m USD
Operating Income
25.7m USD
Other Expenses
-3.9m USD
Net Income
21.8m USD

Free Cash Flow Analysis
STAAR Surgical Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

STAA Profitability Score
Profitability Due Diligence

STAAR Surgical Co's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROIC
Positive Free Cash Flow
55/100
Profitability
Score

STAAR Surgical Co's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

STAA Solvency Score
Solvency Due Diligence

STAAR Surgical Co's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

STAAR Surgical Co's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STAA Price Targets Summary
STAAR Surgical Co

Wall Street analysts forecast STAA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STAA is 43.84 USD with a low forecast of 27.27 USD and a high forecast of 63 USD.

Lowest
Price Target
27.27 USD
2% Upside
Average
Price Target
43.84 USD
64% Upside
Highest
Price Target
63 USD
136% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STAA?

Click here to dive deeper.

Dividends

STAAR Surgical Co
does not pay dividends
Shareholder Yield

Current shareholder yield for STAA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STAA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

STAA News

Other Videos

Profile

STAAR Surgical Co Logo
STAAR Surgical Co

Country

United States of America

Industry

Health Care

Market Cap

1.3B USD

Dividend Yield

0%

Description

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

Contact

CALIFORNIA
Lake Forest
25651 Atlantic Ocean Drive
+16263037902.0
staar.com

IPO

1983-07-08

Employees

692

Officers

President, CEO & Chairman
Mr. Thomas G. Frinzi
Chief Financial Officer
Mr. Patrick F. Williams
Chief Operating Officer
Mr. Warren Foust
Chief Technology Officer
Dr. Keith Holliday Ph.D.
Chief Medical Officer
Dr. Scott D. Barnes M.D.
Vice President of Investor Relations & Corporate Development
Mr. Brian Moore
Show More
General Counsel & Corporate Secretary
Mr. Nathaniel B. Sisitsky Esq.
Chief Marketing Officer
Ms. Nancy Sabin
Senior Vice President of Commercial Operations - North America & APAC
Mr. James Francese
Chief Clinical, Regulatory & Medical Affairs Officer
Dr. Magda Michna Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one STAA stock?

The intrinsic value of one STAA stock under the Base Case scenario is 22.19 USD.

Is STAA stock undervalued or overvalued?

Compared to the current market price of 26.68 USD, STAAR Surgical Co is Overvalued by 17%.

Back to Top